Detachable microfluidic device implemented with electrochemical aptasensor (DeMEA) for sequential analysis of cancerous exosomes

Leila Kashefi-Kheyrabadi, Junmoo Kim, Sudesna Chakravarty, Sunyoung Park, Hogyeong Gwak, Seung Il Kim, Mohsen Mohammadniaei, Min Ho Lee, Kyung A. Hyun, Hyo Il Jung

Research output: Contribution to journalArticlepeer-review

Abstract

The quantification of cancer-derived exosomes has a strong potential for minimally invasive diagnosis of cancer during its initial stage. As cancerous exosomes form a small fraction of all the exosomes present in blood, ultra-sensitive detection is a prerequisite for the development of exosome-based cancer diagnostics. Herein, a detachable microfluidic device implemented with an electrochemical aptasensor (DeMEA) is introduced for highly sensitive and in-situ quantification of cancerous exosomes. To fabricate the aptasensor, a nanocomposite was applied on the electrode surface followed by electroplating of gold nanostructures. Subsequently, an aptamer against an epithelial cell adhesion molecule is immobilized on the electrode surface to specifically detect cancer-specific exosomes. A microfluidic vortexer is then constructed and implemented in the sensing system to increase the collision between the exosomes and sensing surface using hydrodynamically generated transverse flow. The microfluidic vortexer was integrated with the aptasensor via a 3D printed magnetic housing. The detachable clamping of the two different devices provides an opportunity to subsequently harvest the exosomes for downstream analysis. The DeMEA has high sensitivity and specificity with an ultra-low limit of detection of 17 exosomes/μL over a wide dynamic range (1 × 102 to 1 × 109) exosomes/μL in a short period. As proof of the concept, the aptasensor can be separated from the 3D printed housing to harvest and analyze the exosomes by real-time polymerase chain reaction. Moreover, the DeMEA quantifies the exosomes from plasma samples of patients with breast cancer at different stages of the disease. The DeMEA provides a bright horizon for the application of microfluidic integrated biosensors for the early detection of cancerous biomarkers.

Original languageEnglish
Article number112622
JournalBiosensors and Bioelectronics
Volume169
DOIs
Publication statusPublished - 2020 Dec 1

Bibliographical note

Funding Information:
The authors acknowledge the Bio-Medical Technology Development Program of the National Research Foundation (NRF) of Korea for providing the following grants: MSIP (No. NRF-2018R1A2A2A15019814 ), (No. NRF-2018R1C1B6002499 ), and (No. 2020R1A5A1018052 ) to carry out this research. The authors are also grateful to the Ministry of Trade, Industry, and Energy (MOTIE) of Korea for providing the following grant (Grant No. 20008829 ).

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biophysics
  • Biomedical Engineering
  • Electrochemistry

Fingerprint Dive into the research topics of 'Detachable microfluidic device implemented with electrochemical aptasensor (DeMEA) for sequential analysis of cancerous exosomes'. Together they form a unique fingerprint.

Cite this